37 results
Page 2 of 2
424B3
dtsn1d sgzxlwt8
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
na2ph 3np0pyof7ti5p
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
F-4
mf2ch04lo zp7cp1jb1t
15 Jun 21
Registration of securities (foreign)
12:00am
20-F
EX-2.7
cluf7
30 Apr 21
Annual report (foreign)
12:53pm
20-F
crny7xwzx gfhv
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.1
n3v 3bfei6slcsngv
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
9qi238
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
ng8s5l3zsnvr
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
qgruak1w22 jp2hqn
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
5bgys944wp072ul
18 Dec 20
Draft registration statement
12:00am
6-K
EX-99.1
2dt7dog dr678k
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
gm2fq
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
424B4
6wxol91fd5tz hx2v3
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
vpb1vllq7
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
dhs88
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
8zqrkmsw0s
29 May 20
Draft registration statement (amended)
12:00am
DRS
2ccaiu
19 Feb 20
Draft registration statement
12:00am